Bentol

Bentol may be available in the countries listed below.

Ingredient matches for Bentol

Sulfadiazine

Sulfadiazine silver (a derivative of Sulfadiazine) is reported as an ingredient of Bentol in the following countries:

• Bangladesh

International Drug Name Search

Thriostaxil

Thriostaxil may be available in the countries listed below.

Ingredient matches for Thriostaxil

Roxithromycin

Roxithromycin is reported as an ingredient of Thriostaxil in the following countries:

• Greece

International Drug Name Search

Naletal

Naletal may be available in the countries listed below.

Ingredient matches for Naletal

Cilostazol

Cilostazol is reported as an ingredient of Naletal in the following countries:

• Indonesia

International Drug Name Search

Hytacand Orifarm

Hytacand Orifarm may be available in the countries listed below.

Ingredient matches for Hytacand Orifarm

Candesartan

Candesartan cilexetil (a derivative of Candesartan) is reported as an ingredient of Hytacand Orifarm in the following countries:

• Denmark

Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Hytacand Orifarm in the following countries:

• Denmark

International Drug Name Search

Coquinone

Coquinone may be available in the countries listed below.

Ingredient matches for Coquinone

Ubidecarenone

Ubidecarenone is reported as an ingredient of Coquinone in the following countries:

• Taiwan

International Drug Name Search

Corensoul

Corensoul may be available in the countries listed below.

Ingredient matches for Corensoul

Tiaramide

Tiaramide hydrochloride (a derivative of Tiaramide) is reported as an ingredient of Corensoul in the following countries:

• Japan

International Drug Name Search

Oxygen

Dosage Form: gas
Oxygen Label

LIQUID Oxygen

Oxygen, REFRIGERATED LIQUID U.S.P.    UN 1073 RX ONLY Oxygen 2

KEEP CONTAINER UPRIGHT

FOR LIQUID WITHDRAWAL WEAR FACE SHIELD and GLOVES

USE HAND TRUCK

DO NOT DROP

ALWAYS KEEP CONTAINER IN UPRIGHT POSITION.

WARNING: EXTREMELY COLD, OXIDIZING LIQUID AND GAS UNDER PRESSURE. VIGOROUSLY ACCELERATES COMBUSTION. COMBUSTIBLES IN CONTACT WITH LIQUID Oxygen MAY EXPLODE ON IGNITION OR IMPACT. CAN CAUSE SEVERE FROSTBITE. Keep oil, grease, and combustibles away. Use only with equipment cleaned for Oxygen service. Store and use with adequate ventilation. Do not get liquid in eyes, on skin, or clothing. For liquid withdrawal, wear face shield and gloves. Do not drop. Use suitable hand truck for container movement. Avoid spills. Do not walk on or roll equipment over spills. Cylinder temperature should not exceed 52C (125F). Close valve after each use and when empty. Use in accordance with the Material Safety Data Sheet. Produced by Air Liquefaction Process.

FIRST AID: IN CASE OF FROSTBITE, obtain medical treatment immediately.

DO NOT REMOVE THIS PRODUCT LABEL.

CHEMTREC EMERGENCY NO. 1-800-424-9300

MELO’S GAS AND GEAR (661) 387-6800

MGG-USP

Oxygen, COMPRESSED USP    UN1072  

Oxygen 2   18033   (R 04/05)

WARNING: For emergency use only when administered by properly trained personnel for Oxygen deficiency and resuscitation.  For all other medical applications, Rx only. Uninterrupted use of high concentrations of Oxygen over a long duration, without monitoring its effect on Oxygen content of arterial blood, may be harmful. Use only with pressure reducing equipment and apparatus designed for use with Oxygen. Do not attempt to use on patients who have stopped breathing, unless used in conjunction with resuscitative equipment.  PRODUCED BY AIR LIQUEFACTION.

WARNING: HIGH PRESSURE OXIDIZING GAS. VIGOROUSLY ACCELERATES COMBUSTION. Keep oil and grease away. Open valve slowly. Store and use with adequate ventilation. Use only with equipment cleaned for Oxygen service and rated for cylinder pressure. Use a back flow preventive device in piping. Close valve after each use and when empty. Cylinder temperature should not exceed 52C (125F). Use in accordance with the Material Safety Data Sheet (MSDS).

CAS: 7782-44-7         DO NOT REMOVE THIS PRODUCT LABEL.

MELO’S GAS AND GEAR    (661) 387-6800

Oxygen  Oxygen  gas

Product Information Product Type HUMAN PRESCRIPTION DRUG NDC Product Code (Source) 24533-001 Route of Administration RESPIRATORY (INHALATION) DEA Schedule

Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Oxygen (Oxygen) Oxygen 990 mL  in 1 L

Inactive Ingredients Ingredient Name Strength No Inactive Ingredients Found

Product Characteristics Color      Score      Shape Size Flavor Imprint Code Contains

Packaging # NDC Package Description Multilevel Packaging 1 24533-001-01 170 L In 1 CYLINDER None 2 24533-001-02 255 L In 1 CYLINDER None 3 24533-001-03 708 L In 1 CYLINDER None 4 24533-001-04 7108 L In 1 CYLINDER None 5 24533-001-05 7985 L In 1 CYLINDER None 6 24533-001-06 129974 L In 1 DEWAR None 7 24533-001-07 155290 L In 1 DEWAR None 8 24533-001-08 168089 L In 1 DEWAR None 9 24533-001-09 172733 L In 1 DEWAR None

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
unapproved medical gas		11/28/2011

Labeler - Melo's Gas and Gear, Inc. (782869080)

Establishment
Name	Address	ID/FEI	Operations
Melo's Gas and Gear, Inc.		078373996	manufacture

Revised: 02/2012Melo's Gas and Gear, Inc.

Anaprilins

Anaprilins may be available in the countries listed below.

Ingredient matches for Anaprilins

Propranolol

Propranolol hydrochloride (a derivative of Propranolol) is reported as an ingredient of Anaprilins in the following countries:

• Latvia

International Drug Name Search

Ketorolac Actavis

Ketorolac Actavis may be available in the countries listed below.

Ingredient matches for Ketorolac Actavis

Ketorolac

Ketorolac tromethamine (a derivative of Ketorolac) is reported as an ingredient of Ketorolac Actavis in the following countries:

• Italy

International Drug Name Search

Sotalol GM

Sotalol GM may be available in the countries listed below.

Ingredient matches for Sotalol GM

Sotalol

Sotalol hydrochloride (a derivative of Sotalol) is reported as an ingredient of Sotalol GM in the following countries:

• Israel

International Drug Name Search

Provinace

Provinace may be available in the countries listed below.

Ingredient matches for Provinace

Perindopril

Perindopril erbumine (a derivative of Perindopril) is reported as an ingredient of Provinace in the following countries:

• Vietnam

International Drug Name Search

Respi-Tann G Suspension

Pronunciation: kar-bay-ta-PEN-tane/gwye-FEN-e-sin
Generic Name: Carbetapentane/Guaifenesin
Brand Name: Allres G

Respi-Tann G Suspension is used for:

Relieving unproductive cough and reducing mucus in the chest due to colds, flu, or hay fever. It may also be used for other conditions as determined by your doctor.

Respi-Tann G Suspension is a cough suppressant and expectorant combination. The cough suppressant works in the brain to help decrease the cough reflex. The expectorant works by thinning mucus (phlegm) in the lungs, making it less sticky and easier to cough up. This makes coughs more productive.

Do NOT use Respi-Tann G Suspension if:

• you are allergic to any ingredient in Respi-Tann G Suspension


• you are taking or have taken a monoamine oxidase inhibitor (MAOI) (eg, phenelzine) with the last 14 days

Contact your doctor or health care provider right away if any of these apply to you.

Before using Respi-Tann G Suspension:

Some medical conditions may interact with Respi-Tann G Suspension. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you have chronic cough due to smoking, asthma, chronic bronchitis, or emphysema, or if your cough produces large amounts of mucus


• if you have a history of heart problems, high blood pressure, prostate problems, an overactive thyroid, diabetes, or glaucoma


• if you have phenylketonuria

Some MEDICINES MAY INTERACT with Respi-Tann G Suspension. Tell your health care provider if you are taking any other medicines, especially any of the following:

• MAOIs (eg, phenelzine) because they may increase the risk of Respi-Tann G Suspension's side effects

This may not be a complete list of all interactions that may occur. Ask your health care provider if Respi-Tann G Suspension may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Respi-Tann G Suspension:

Use Respi-Tann G Suspension as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• Take Respi-Tann G Suspension by mouth with or without food.


• Drinking extra fluids while you are taking Respi-Tann G Suspension is recommended. Check with your doctor for instructions.


• Shake well before each use.


• Use a measuring device marked for medicine dosing. Ask your pharmacist for help if you are unsure of how to measure your dose.


• If you miss a dose of Respi-Tann G Suspension and you are taking it regularly, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Respi-Tann G Suspension.

Important safety information:

• Respi-Tann G Suspension may cause drowsiness. These effects may be worse if you take it with alcohol or certain medicines. Use Respi-Tann G Suspension with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.


• Do not drink alcohol or use medicines that may cause drowsiness (eg, sleep aids, muscle relaxers) while you are using Respi-Tann G Suspension; it may add to their effects. Ask your pharmacist if you have questions about which medicines may cause drowsiness.


• Do not use Respi-Tann G Suspension for a cough with a lot of mucous. Do not use it for a long-term cough (eg, caused by asthma, emphysema, smoking). However, you may use it for these conditions if your doctor tells you to.


• If cough persists for more than 1 week or is accompanied by a fever, contact your health care provider. A persistent cough could be a sign of a serious condition.


• Some of these products contain phenylalanine. If you must have a diet that is low in phenylalanine, ask your pharmacist if it is in your product.


• Respi-Tann G Suspension may interfere with certain lab tests. Be sure your doctor and lab personnel know you are taking Respi-Tann G Suspension.


• Caution is advised when using Respi-Tann G Suspension in CHILDREN; they may be more sensitive to its effects.


• PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Respi-Tann G Suspension while you are pregnant. It is not known if Respi-Tann G Suspension is found in breast milk. If you are or will be breast-feeding while you use Respi-Tann G Suspension, check with your doctor. Discuss any possible risks to your baby.

Possible side effects of Respi-Tann G Suspension:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Drowsiness; dry mouth, nose, or throat; upset stomach.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue).

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Respi-Tann G side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include restlessness; seizures; severe agitation.

Proper storage of Respi-Tann G Suspension:

Store Respi-Tann G Suspension at room temperature, between 68 and 77 degrees F (20 and 25 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Respi-Tann G Suspension out of the reach of children and away from pets.

General information:

• If you have any questions about Respi-Tann G Suspension, please talk with your doctor, pharmacist, or other health care provider.


• Respi-Tann G Suspension is to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Respi-Tann G Suspension. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Respi-Tann G resources

• Respi-Tann G Side Effects (in more detail)
• Respi-Tann G Use in Pregnancy & Breastfeeding
• Respi-Tann G Drug Interactions
• Respi-Tann G Support Group
• 0 Reviews for Respi-Tann G - Add your own review/rating

Compare Respi-Tann G with other medications

• Cough

Haloperidol Iqfarma

Haloperidol Iqfarma may be available in the countries listed below.

Ingredient matches for Haloperidol Iqfarma

Haloperidol

Haloperidol is reported as an ingredient of Haloperidol Iqfarma in the following countries:

• Peru

International Drug Name Search

Ulobétasol

Ulobétasol may be available in the countries listed below.

Ingredient matches for Ulobétasol

Ulobetasol

Ulobétasol (DCF) is also known as Ulobetasol (Rec.INN)

International Drug Name Search

Glossary

DCF	Dénomination Commune Française
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.